Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research focused on Placebo and Everolimus, with related work in Acute kidney injury, Radiation therapy, Cancer research. Notable publications include 'Incidence and Risk Factors of in-hospital mortality from AKI after non-cardiovascular operation: A nationwide Survey in China', 'Individualized Adaptive Radiotherapy versus Standard Radiotherapy with Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer: A Multicenter Randomized Phase...', and 'Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A'.
Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A
1998P Antitumor activity and safety profile of trilaciclib in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC) receiving chemotherapy (TRACES): Updated results from TRACES
Individualized Adaptive Radiotherapy versus Standard Radiotherapy with Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer: A Multicenter Randomized Phase III Clinical Trial CRTOG1601
MA14.05 A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
Incidence and Risk Factors of in-hospital mortality from AKI after non-cardiovascular operation: A nationwide Survey in China